Vascularized composite allotransplant in the realm of regenerative plastic surgery

Mayo Clinic Proceedings

Volumn 89, Issue 7, 2014, Pages 1009-1020

  Chim, Harvey ^a   Amer, Hatem ^a   Mardini, Samir ^a   Moran, Steven L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; CYCLOSPORIN; DACLIZUMAB; FINGOLIMOD; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

CONFERENCE PAPER; FACIAL TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; HAND TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE; MEDICAL LITERATURE; NEPHROTOXICITY; NERVE REGENERATION; OUTCOME ASSESSMENT; PLASTIC SURGERY; PREVENTIVE MEDICINE; PRIMARY MEDICAL CARE; REGENERATION; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TISSUE INDUCTION; TREATMENT INDICATION; VASCULAR DISEASE; VASCULARIZED COMPOSITE ALLOTRANSPLANTATION;

FACIAL INJURIES; FACIAL TRANSPLANTATION; GUIDED TISSUE REGENERATION; HAND INJURIES; HAND TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; TISSUE ENGINEERING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84904609104     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2014.05.009     Document Type: Conference Paper

References (88)

1. Amer H, Carlsen BT, Dusso JL, Edwards BS, Moran SL. Hand transplantation. Minn Med. 2011;94(5):40-43.
2. Merrill JP, Murray JE, Harrison JH, Guild WR. Successful homotransplantation of the human kidney between identical twins. J Am Med Assoc. 1956;160(4):277-282.
3. Sayegh MH, Carpenter CB. Transplantation 50 years laterd progress, challenges, and promises. N Engl J Med. 2004; 351(26):2761-2766.
4. Morris PJ. Transplantationda medical miracle of the 20th century. N Engl J Med. 2004;351(26):2678-2680.
5. Murray JE. Organ transplantation (skin, kidney, heart) and the plastic surgeon. Plast Reconstr Surg. 1971;47(5):425-431.
6. Gilbert R. Transplant is successful with a cadaver forearm. Med Trib Med News. 1964;5:20-22.
7. Gilbert R. Hand transplanted from cadaver is reampuated. Med Trib Med News. 1964;5:23-25.
8. Zand MS. Immunosuppression and immune monitoring after renal transplantation. Semin Dial. 2005;18(6):511-519.
9. Dubernard JM, Owen E, Herzberg G, et al. Human hand allograft: report on first 6 months. Lancet. 1999;353(9161):1315-1320.
10. Dubernard J-M, Lengelé B, Morelon E, et al. Outcomes 18 months after the first human partial face transplantation. N Engl J Med. 2007;357(24):2451-2460.
11. Siemionow M, Gharb BB, Rampazzo A. Successes and lessons learned after more than a decade of upper extremity and face transplantation. Curr Opin Organ Transplant. 2013;18(6): 633-639.
12. Karabekmez FE, Duymaz A, Moran SL. Early clinical outcomes with the use of decellularized nerve allograft for repair of sensory defects within the hand. Hand (N Y). 2009;4(3):245-249.
13. Iorio ML, Shuck J, Attinger CE. Wound healing in the upper and lower extremities: a systematic review on the use of acellular dermal matrices. Plast Reconstr Surg. 2012;130(5, suppl 2): 232S-241S.
14. Lim ML, Jungebluth P, Ajalloueian F, et al. Whole organ and tissue reconstruction in thoracic regenerative surgery. Mayo Clin Proc. 2013;88(10):1151-1166.
15. Macchiarini P, Jungebluth P, Go T, et al. Clinical transplantation of a tissue-engineered airway [published correction appears in Lancet. 2009;373(9662):462]. Lancet. 2008;372(9655):2023-2030.
16. Orlando G, Baptista P, Birchall M, et al. Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transpl Int. 2011;24(3):223-232.
17. Bueno EM, Diaz-Siso JR, Sisk GC, et al. Vascularized composite allotransplantation and tissue engineering. J Craniofac Surg. 2013; 24(1):256-263.
18. Carlsen BT, Prigge P, Peterson J. Upper extremity limb loss: functional restoration from prosthesis and targeted reinnervation to transplantation. J Hand Ther. 2014;27(2):106-113.
19. Landin L, Bonastre J, Casado-Sanchez C, et al. Outcomes with respect to disabilities of the upper limb after hand allograft transplantation: a systematic review. Transpl Int. 2012;25(4):424-432.
20. Glaus SW, Johnson PJ, Mackinnon SE. Clinical strategies to enhance nerve regeneration in composite tissue allotransplantation. Hand Clin. 2011;27(4):495-509.
21. Carty MJ, Bueno EM, Lehmann LS, Pomahac B. A position paper in support of face transplantation in the blind. Plast Reconstr Surg. 2012;130(2):319-324.
22. Petruzzo P, Lanzetta M, Dubernard JM, et al. The International Registry on Hand and Composite Tissue Transplantation. Transplantation. 2010;90(12):1590-1594.
23. Conrad A, Brunet AS, Hervieu V. Epstein-Barr virus-associated smooth muscle tumors in a composite tissue allograft and a pediatric liver transplant recipient. Transpl Infect Dis. 2013;15(5): E182-E186.
24. Amirlak B, Gonzalez R, Gorantla V, Beidenbach WC III, Tobin GR. Creating a hand transplant program. Clin Plast Surg. 2007;34(2):279-289.
25. Kumnig M, Jowsey SG, Rumpold G, et al. The psychological assessment of candidates for reconstructive hand transplantation. Transpl Int. 2012;25(5):573-585.
26. Weissenbacher A, Hautz T, Pratschke J, Schneeberger S. Vascularized composite allografts and solid organ transplants: similarities and differences. Curr Opin Organ Transplant. 2013;18(6): 640-644.
27. Bonastre J, Landin L, Diez J, Casado-Sanchez C, Casado-Perez C. Factors influencing acute rejection of human hand allografts: a systematic review. Ann Plast Surg. 2012;68(6):624-629.
28. Schneeberger S, Morelon E, Landin L. ESOT CTA Committee. Vascularized composite allotransplantation: a member of the transplant family? Transplantation. 2012;93(11):1088-1091.
29. Department of Health and Human Services. Final rule. Federal Register, The Daily Journal of the United States Government. 2013; 7/3:40033-40034-40042.
30. Malt RA, McKhann CF. Replantation of severed arms. JAMA. 1964;189:716-722.
31. Tamai S. Twenty years' experience of limb replantationd review of 293 upper extremity replants. J Hand Surg Am. 1982;7(6):549-556.
32. Matsuhara K, Tamai S, Fukunishi H, Obama K, Komatsu S. Experience with reanastomosis of the amputated thumb [in Japanese]. Seikei Geka. 1967;18(4):403-404.
33. Breidenbach WC, Gonzales NR, Kaufman CL, Klapheke M, Tobin GR, Gorantla VS. Outcomes of the first 2 American hand transplants at 8 and 6 years posttransplant. J Hand Surg Am. 2008;33(7):1039-1047.
34. Solway S, Beaton DE, McConnell S, Bombardier C. The DASH Outcome Measure User's Manual. 3rd ed. Toronto, Ontario: Institute for Work & Health; 2012.
35. Dellon AL, Curtis RM, Edgerton MT. Reeducation of sensation in the hand after nerve injury and repair. Plast Reconstr Surg. 1974;53(3):297-305.
36. Pei G, Xiang D, Wang G, et al. A report of 15 hand allotransplantations in 12 patients and their outcomes in China. Transplantation. 2012;94(10):1052-1059.
37. Cavadas PC, Landin L, Thione A, et al. The Spanish experience with hand, forearm, and arm transplantation. Hand Clin. 2011; 27(4):443-453.
38. Schuind F, Van Holder C, Mouraux D, et al. The first Belgian hand transplantationd37 month term results. J Hand Surg Br. 2006;31(4):371-376.
39. Jablecki J, Kaczmarzyk L, Patrzalek D, Domanasiewicz A, Boratyńska Z. First Polish forearm transplantation: report after 17 months. Transplant Proc. 2009;41(2):549-553.
40. Jablecki J, Kaczmarzyk L, Domanasiewicz A, Chelmoński A, Kaczmarzyk J. Unilateral hand transplantdresults after 41 months. Transplant Proc. 2013;45(1):440-443.
41. Jablecki J, Kaczmarzyk L, Domanasiewicz A, et al. Result of armlevel upper-limb transplantation in two recipients at 19- and 30-month follow-up. Ann Transplant. 2012;17(3):126-132.
42. Petruzzo P, Dubernard JM. The International Registry on Hand and Composite Tissue Allotransplantation. Clin Transpl. 2011; 247-253.
43. Kalliainen LK. Supporting facial transplantation with the pillars of bioethics. J Reconstr Microsurg. 2010;26(8):547-554.
44. Pirnay P, Foo R, Hervé C, Meningaud JP. Ethical questions raised by the first allotransplantations of the face: a survey of French surgeons. J Craniomaxillofac Surg. 2012;40(8):e402-e407.
45. Petruzzo P, Testelin S, Kanitakis J, et al. First human face transplantation: 5 years outcomes. Transplantation. 2012;93(2): 236-240.
46. Shanmugarajah K, Hettiaratchy S, Butler PE. Facial transplantation. Curr Opin Otolaryngol Head Neck Surg. 2012;20(4):291-297.
47. Chang G, Pomahac B. Psychosocial changes 6 months after face transplantation. Psychosomatics. 2013;54(4):367-371.
48. Coffman KL, Siemionow MZ. Face transplantation: psychological outcomes at three-year follow-up. Psychosomatics. 2013; 54(4):372-378.
49. Edrich T, Cywinski JB, Colomina MJ, et al. Perioperative management of face transplantation: a survey. Anesth Analg. 2012; 115(3):668-670.
50. Sedaghati-nia A, Gilton A, Liger C, et al. Anaesthesia and intensive care management of face transplantation. Br J Anaesth. 2013;111(4):600-606.
51. Knoll BM, Hammond SP, Koo S, et al. Infections following facial composite tissue allotransplantationdsingle center experience and review of the literature. Am J Transplant. 2013;13(3):770-779.
52. Zuker RM, Redett R, Alman B, Coles JG, Timoney N, Ein SH. First successful lower-extremity transplantation: technique and functional result. J Reconstr Microsurg. 2006;22(4):239-244.
53. Fattah A, Cypel T, Donner EJ, Wang F, Alman BA, Zuker RM. The first successful lower extremity transplantation: 6-year follow-up and implications for cortical plasticity. Am J Transplant. 2011;11(12):2762-2767.
54. de Lago M. World's first double leg transplantation is carried out in Spain. BMJ. 2011;343(18):d4541.
55. Cavadas PC, Thione A, Carballeira A, Blanes M. Bilateral transfemoral lower extremity transplantation: result at 1 year. Am J Transplant. 2013;13(5):1343-1349.
56. McCarthy ML, MacKenzie EJ, Edwin D, Bosse MJ, Castillo RC, Starr A; LEAP Study Group. Psychological distress associated with severe lower-limb injury. J Bone Joint Surg Am. 2003; 85(9):1689-1697.
57. Carty MJ, Zuker R, Cavads P, Pribaz JJ, Talbot SG, Pomahac B. The case for lower extremity allotransplantation. Plast Reconstr Surg. 2013;131(6):1272-1277.
58. Tukiainen E, Suominen E, Asko-Seljavaara S. Replantation, revascularization, and reconstruction of both legs after amputations: a case report. J Bone Joint Surg Am. 1994;76(11):1712-1716.
59. Schmidhammer R, Huber W, Pelinka LE, Haller H, Kroepfl A. Simultaneous bilateral lower leg replantation: evaluation by different scoring systemsda critical analysis. J Trauma. 2004; 57(3):648-652.
60. Ozkan O, Akar ME, Ozkan O, et al. Preliminary results of the first human uterus transplantation from a multiorgan donor. Fertil Steril. 2013;99(2):470-476.
61. Brännström M, Johannesson L, Dahm-Kähler P, et al. First clinical uterus transplantation trial: a six-month report. Fertil Steril. 2014;101(5):1228-1236.
62. Brännström M, Diaz-Garcia C, Hanafy A, Olausson M, Tzakis A. Uterus transplantation: animal research and human possibilities. Fertil Steril. 2012;97(6):1269-1276.
63. Berli JU, Broyles JM, Lough D, et al. Current concepts and systematic review of vascularized composite allotransplantation of the abdominal wall. Clin Transplant. 2013;27(6):781-789.
64. Levi DM, Tzakis AG, Kato T, et al. Transplantation of the abdominal wall. Lancet. 2003;361(9376):2173-2176.
65. Agarwal S, Dorafshar AH, Harland RC, Millis JM, Gottlieb LJ. Liver and vascularized posterior rectus sheath fascia composite tissue allotransplantation. Am J Transplant. 2010;10(12):2712-2716.
66. Lee JC, Olaitan OK, Lopez-Soler R, Renz JF, Millis JM, Gottlieb LJ. Expanding the envelope: the posterior rectus sheath-liver vascular composite allotransplant. Plast Reconstr Surg. 2013;131(2):209e-218e.
67. Jin J, Williams CP, Soltanian H, et al. Use of abdominal wall allotransplantation as an alternative for the management of end stage abdominal wall failure in a porcine model. J Surg Res. 2010;162(2):314-320.
68. Diefenbeck M, Wagner F, Kirschner MH, Nerlich A, Mückley T, Hofmann GO. Outcome of allogeneic vascularized knee transplants. Transpl Int. 2007;20(5):410-418.
69. Diefenbeck M, Nerlich A, Schneeberger S, Wagner F, Hofmann GO. Allograft vasculopathy after allogeneic vascularized knee transplantation. Transpl Int. 2011;24(1):e1-e5.
70. Diaz-Siso JR, Bueno RM, Sisk GC, Marty FM, Pomahac B, Tullius SG. Vascularized composite tissue allotransplantationd state of the art. Clin Transplant. 2013;27(3):330-337.
71. Leonard DA, Kurtz JM, Cetrulo CL Jr. Vascularized composite allotransplantation: towards tolerance and the importance of skin-specific immunobiology. Curr Opin Organ Transplant. 2013;18(6):645-651.
72. Chang J, Davis CL, Mathes DW. The impact of current immunosuppression strategies in renal transplantation on the field of reconstructive transplantation. J Reconstr Microsurg. 2012;28(1):7-19.
73. Fontes P, Rao AS, Demetris AJ, et al. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet. 1994;344(8916):151-155.
74. Ciancio G, Miller J, Garcia-Morales RO, et al. Six-year clinical effect of donor bone marrow infusions in renal transplant patients. Transplantation. 2001;71(7):827-835.
75. Schneeberger S, Gorantla VS, Brandacher G, et al. Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg. 2013;257(2):345-351.
76. International Hand and Composite Tissue Allotransplantation Society update. The Transplantation Society website. https://www.tts.org/index.php? option=com-content&view=article&id=1439:international-hand-and- composite-tissue-allotransplantationsociety-update&catid=116: newsletter-2013-volume-10-issue- 3&Itemid=603. Accessed March 8, 2014.
77. Starzl TE, Murase N, Abu-Elmagd K, et al. Tolerogenic immunosuppression for organ transplantation. Lancet. 2003;361(9368): 1502-1510.
78. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med. 2008;358(4):353-361.
79. Leventhal J, Abecassis M, Miller J, et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med. 2012;4(124):124ra28.
80. Klapheke M. The role of the psychiatrist in organ transplantation. Bull Menninger Clin. 1999;63(1):13-39.
81. Klapheke MM, Marcell C, Taliaferro G, Creamer B. Psychiatric assessment of candidates for hand transplantation. Microsurgery. 2000;20(8):453-457.
82. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363(9419):1439-1441.
83. Alagesan S, Griffin MD. Autologous and allogeneic mesenchymal stem cells in organ transplantation: what do we know about their safety and efficacy? Curr Opin Organ Transplant. 2014;19(1):65-72.
84. Kuo YR, Chen CC, Shih HS, et al. Prolongation of composite tissue allotransplant survival by treatment with bone marrow mesenchymal stem cells is correlated with T-cell regulation in a swine hind-limb model. Plast Reconstr Surg. 2011;127(2): 569-579.
85. Plock JA, Schnider JT, Solari MG, Zheng XX, Gorantla VS. Perspectives on the use of mesenchymal stem cells in vascularized composite allotransplantation. Front Immunol. 2013;4:175.
86. Pan H, Zhao K, Wang L, et al. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hindlimb allografts after bone marrow transplantation. J Surg Res. 2010;160(2):315-324.
87. Rennert RC, Sorkin M, Wong VW, Gurtner GC. Organ-level tissue engineering using bioreactor systems and stem cells: implications for transplant surgery. Curr Stem Cell Res Ther. 2014; 9(1):2-9.
88. Brandacher G, Lee WP, Schneeberger S. Minimizing immunosuppression in hand transplantation. Expert Rev Clin Immunol. 2012;8(7):673-683.